Comparison of the prognostic value of mitotic frequency and mitotic activity index in breast cancer

Breast

Volumn 5, Issue 1, 1996, Pages 31-36

  Jannink, I ^a   Van Diest, P J ^a   Baak, J P A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MITOSIS; MITOSIS RATE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030070442     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(96)90046-6     Document Type: Article

References (16)

1. Bonnadonna G, Valagussa P, Rossi A et al. 10-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 1985; 5: 95-115.
2. Linden J C van der, Lindeman J, Baak J P A, Meijer C J L M, Herman C J. The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry 1989; 10: 56-61.
3. Tosi P, Luzi P, Sforza V et al. Correlation between morphometrical parameters and disease free-survival in ductal breast cancer treated by only surgery. Appl Pathol 1986; 4: 33-42.
4. Uyterlinde A M, Baak J P A, Schipper N W, Peterse H, Matze E, Meijer C J L M. Further evaluation of the prognostic value of morphometric and flow cytometric features in breast cancer patients with long-term follow-up. Int J Cancer 1990; 45: 1-7.
5. Uyterlinde A M, Schipper N W, Baak J P A. Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer. J Clin Pathol 1987; 40: 1432-1436.
6. Linden J C van der, Baak J P A, Lindeman J, Hermans J, Meijer C J L M. Prospective evaluation of the prognostic value of morphometry in primary breast cancer patients. J Clin Pathol 1987; 40: 302-306.
7. Diest P J van, Baak J P A. The morphometric multivariate prognostic index (MPI) is the strongest prognosticator in premenopausal lymph node negative and lymph node positive breast cancer patients. Hum Pathol 1991; 22: 326-330.
8. Baak J P A, Wisse-Brekelmans E C M, Kurver P H J, Gorp L H M van, Voorhorst F J, Miettinen O S. Regional differences in breast survival are correlated with differences in differentiation and rate of proliferation. Hum Pathol 1992; 23: 989-992.
9. Baak J P A, Noteboom E, Koevoets J J M. The influence of fixatives and other variations in tissue processing on nuclear morphometric features. Anal Quant Cytol Histol 1989; 11: 219-224.
10. Baak J P A. Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis. N Y, Heidelberg: Springer, 1991.
11. Baak J P A. Counting mitoses (Editorial). Hum Pathol 1990; 21: 683-685.
12. Kate T K, Beliën J A M, Smeulders A W M, Baak J P A. Method for counting mitoses by image processing in Feulgen stained breast cancer. Cytometry 1993; 14: 241-250.
13. Donhuijsen K. Mitosis counts: reproducibility and significance in grading of malignancy. Hum Pathol 1986; 17: 112-1125.
14. Montironi R, Collan Y, Scarpelli M et al. Reproducibility of mitotic figures in malignant glial tumours. Appl Pathol [APP] 1988; 6: 258-265.
15. Diest P J van, Baak J P A et al. Reproducibility of mitoses counting in 2469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 1992; 23: 603-607.
16. Simpson J F, Dutt P L, Page D L. Expression of mitosis per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol 1992; 23: 608-611.